Related Experiment Video
Updated: May 5, 2026

12:19
Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
60.4K
Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1
Marc Kvansakul1, Andrew H Wei, Jamie I Fletcher
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Plos Pathogens
|January 5, 2011
Summary
Epstein-Barr virus (EBV) protein BHRF1 promotes cancer by blocking cell death. Targeting BHRF1 is crucial for treating EBV-associated malignancies like Burkitt lymphoma.
Area of Science:
- Virology and Molecular Biology
- Cancer Research
- Structural Biology
Background:
- Epstein-Barr virus (EBV) is linked to B cell malignancies, including Burkitt lymphoma.
- The EBV-encoded BHRF1 protein mimics the human anti-apoptotic protein Bcl-2, promoting viral infectivity and lymphomagenesis.
Purpose of the Study:
- To investigate the interactions of BHRF1 with host pro-apoptotic proteins.
- To understand the structural basis of BHRF1's inhibition of apoptosis.
- To assess the therapeutic implications of targeting BHRF1 in EBV-associated cancers.
Main Methods:
- Structural analysis of BHRF1 in complex with Bim and Bak.
- Assessment of BHRF1's impact on cytotoxic agent sensitivity in a Burkitt lymphoma mouse model.
Main Results:
- BHRF1 binds to multiple pro-apoptotic proteins, including Bim, Bid, Puma, and Bak.
- BHRF1 expression confers significant resistance to cytotoxic agents.
- BHRF1 renders a mouse model of Burkitt lymphoma untreatable with current therapies.
Conclusions:
- BHRF1 plays a critical role in EBV-driven lymphomagenesis by inhibiting apoptosis.
- Existing Bcl-2 antagonists do not target BHRF1, highlighting a therapeutic gap.
- The determined structures of BHRF1-Bim and BHRF1-Bak complexes can guide the development of novel BHRF1 inhibitors for EBV-associated malignancies.
More Related Videos
Related Concept Videos
Long-patch Base Excision Repair
6.3K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
6.3K
NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K
Caspases
8.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.7K
The Extrinsic Apoptotic Pathway
6.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K

